Qualisure News Sort by Date Posted: Newest first Oldest first Search by Keywords: Search Clear Dr. Cynthia Stretch (CSO) gave a podium presentation at the Annual Meeting of the Canadian Association of Surgical Oncologists Dr. Cynthia Stretch (Chief Scientific Officer) presented details on the molecular features of molecular subgroups of papillary thyroid cancer that are identifiable using Thyroid GuidePx™ at the Annual Meeting of the Canadian Association of Surgical Oncologists (CSSO). In her presentation entitled “A Biologically Informative Gene Signature Identified by Machine Learning Predicts Outcomes in Papillary Thyroid […] May 6, 2021 1 min read Qualisure submits an international PCT patent application for the molecular subclassification of papillary thyroid cancer Qualisure has submitted an international PCT patent application for the molecular subclassification of papillary thyroid cancer which is ending review. The Patent Cooperation treaty (PCT) is an international treaty with more than 150 Contracting States. The PCT makes it possible to seek patent protection for an invention simultaneously in a large number of countries by […] April 1, 2021 1 min read Qualisure is awarded a $100,000 Voucher grant from Alberta Innovates Qualisure was awarded a $100,000 voucher from Alberta Innovates to support further development of lead product Thyroid GuidePx™. The voucher will be applied to performing final validation tests of the clinical assay in preparation for clinical implementation. Alberta Innovates vouchers help Alberta’s high potential, high growth, technology and knowledge-based small- and medium-sized enterprises (SMEs) with […] November 10, 2020 1 min read University of Calgary invests $150,000 in Qualisure through the UCeed Health Fund Following an extensive evaluation of Qualisure Diagnostics; technology and commercialization plan, the University of Calgary invested in Qualisure Diagnostics Inc. through the UCeed program. The investment will be instrumental in advancing Qualisure’s technology development and commercialization efforts. The support received from UCeed is also expected to encourage further private investment in Qualisure. UCeed is a […] October 29, 2020 1 min read Dr. Oliver Bathe (CEO) and collaborators are awarded the Jennifer Gardiner Award in Surgical Oncology Research The University of Calgary Department of Oncology and the Arnie Charbonneau Cancer Institute awarded $18,750 to Dr. Bathe and colleagues in endocrine surgery and pathology. The seed grant will be used to test Thyroid GuidePx™ in formalin fixed paraffin embedded fine needle aspirates. These test results will further validate the clinical utility of our test. […] September 25, 2020 1 min read Qualisure announces partnership with Orlando, Florida-based Protean BioDiagnostics Inc. Qualisure Diagnostics Inc. and Protean BioDiagnostics Inc. together will perform the technical validation essential to launch Thyroid GuidePx™ as a Laboratory Developed Test in the United States. Protean BioDiagnostics is a CAP/CLIA certified lab focused on Precision Oncology. Protean’s commitment to deploying the latest and highest quality laboratory diagnostic tools to guide oncology care is […] September 2, 2020 1 min read No more posts to show
